£148.21

Springer Molecularly Targeted Therapy for Childhood Cancer

Price data last checked 38 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£148 today · previous high £148 · all-time low £146

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 53 days · 53 data points (no recent data)

Historical
Generating forecast…
£148.21 £145.47 £146.07 £146.67 £147.26 £147.86 £148.46 26 June 2026 09 July 2026 22 July 2026 04 August 2026 17 August 2026

Price Distribution

Price distribution over 53 days • 2 price levels

Days at Price
Current Price
52 days 1 day · current 0 13 26 39 52 £146 £148 Days at Price

Price Analysis

Most common price: £146 (52 days, 98.1%)

Price range: £146 - £148

Price levels: 2 different prices over 53 days

Description

Each chapter will focus on the known molecular characteristics of specific childhood cancers, focusing on how the molecular ‘drivers’ can be exploited from a therapeutic standpoint with currently available targeted agents. Where applicable, integration of targeted therapies with conventional cytotoxic agents will be considered. This volume will provide a comprehensive summary of molecular characteristics of childhood cancers, and how the changes involved in transformation provide us with opportunities for developing relatively less toxic, but curative, therapies.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
23 August 2014
Listed Since
27 August 2014

Barcode

No barcode data available

Similar Products You Might Like

Immunotherapy for Pediatric Malignancies
87% match

Immunotherapy for Pediatric Malignancies

Springer

£113.90 08 Aug 2026
Survivors of Childhood and Adolescent Cancer: A Multidisciplinary Approach (Pediatric Oncology)
87% match

Survivors of Childhood and Adolescent Cancer: A Multidisciplinary Approach (Pediatric Oncology)

Springer

£104.18 03 Aug 2026
Molecular Targeted Therapy of Lung Cancer
87% match

Molecular Targeted Therapy of Lung Cancer

Springer

£113.79 08 Aug 2026
Cancer in Children, Second Revised and Enlarge Edition: Clinical Management (UICC Current Treatment of Cancer)
87% match

Cancer in Children, Second Revised and Enlarge Edition: Clinical Management (UICC Current Treatment of Cancer)

Springer

£89.99 05 Aug 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
86% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£80.67 05 Aug 2026
Current Cancer Therapeutics
86% match

Current Cancer Therapeutics

Springer

£72.12 30 Jul 2026
Gene-Based Therapies for Cancer (Current Cancer Research)
86% match

Gene-Based Therapies for Cancer (Current Cancer Research)

Springer

£108.01 06 Aug 2026
Pediatric Bone and Soft Tissue Sarcomas (Pediatric Oncology)
86% match

Pediatric Bone and Soft Tissue Sarcomas (Pediatric Oncology)

Springer

£103.27 08 Aug 2026
Childhood Acute Lymphoblastic Leukemia
86% match

Childhood Acute Lymphoblastic Leukemia

Springer

£92.00 06 Aug 2026
RNA-Based Cancer Therapeutics: Techniques, Applications and Challenges in Prognosis
85% match

RNA-Based Cancer Therapeutics: Techniques, Applications and Challenges in Prognosis

Springer

£194.99 13 Aug 2026
Neuroblastoma: 1 (Pediatric Cancer, 1)
85% match

Neuroblastoma: 1 (Pediatric Cancer, 1)

Springer

£129.99 08 Aug 2026
Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models
85% match

Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models

Springer

£74.57 08 Aug 2026
Cancer Genetics and Therapeutics: Focus on Phytochemicals
85% match

Cancer Genetics and Therapeutics: Focus on Phytochemicals

Springer

£76.42 05 Aug 2026
Drug Therapy and Interactions in Pediatric Oncology: A Pocket Guide
85% match

Drug Therapy and Interactions in Pediatric Oncology: A Pocket Guide

Springer

£84.04 04 Aug 2026
Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)
84% match

Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)

Springer

£166.02 07 Aug 2026
Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)
84% match

Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)

Springer

£108.01 08 Aug 2026
Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)
84% match

Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)

Springer

£108.01 05 Aug 2026
Resistance to Immunotoxins in Cancer Therapy: 6 (Resistance to Targeted Anti-Cancer Therapeutics, 6)
84% match

Resistance to Immunotoxins in Cancer Therapy: 6 (Resistance to Targeted Anti-Cancer Therapeutics, 6)

Springer

£76.42 06 Aug 2026
Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology
84% match

Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology

Springer

£113.73 29 Jul 2026
Pharmaceutical Perspectives of Cancer Therapeutics
84% match

Pharmaceutical Perspectives of Cancer Therapeutics

Springer

£179.99 08 Aug 2026
Supportive Care in Pediatric Oncology: A Practical Evidence-Based Approach
84% match

Supportive Care in Pediatric Oncology: A Practical Evidence-Based Approach

Springer

£114.81 08 Aug 2026
Receptor Tyrosine Kinases in Cancer (Cancer Drug Discovery and Development)
84% match

Receptor Tyrosine Kinases in Cancer (Cancer Drug Discovery and Development)

Springer

£108.01 31 Aug 2026
Molecular Targeting in Oncology (Cancer Drug Discovery and Development)
84% match

Molecular Targeting in Oncology (Cancer Drug Discovery and Development)

Humana

£148.21 05 Aug 2026
Molecular Precision Medicine in Cancer (Cancer Drug Discovery and Development)
84% match

Molecular Precision Medicine in Cancer (Cancer Drug Discovery and Development)

Springer

£166.80 27 Aug 2026